Latest Breaking News On - சுவாசிக்கவும் சுலபம் - Page 1 : comparemela.com

Date Time ResApp: Publication of COPD data and new commercial agreement Digital health company ResApp Health (ASX:RAP) has announced the publication of acute exacerbation of chronic obstructive pulmonary disease data from its Breathe Easy adult clinical study and a new commercial agreement with Australian-based telehealth company Doctors on Demand. ResApp Health is developing smartphone applications for the diagnosis and management of respiratory disease. The data from its Breathe Easy adult clinical study has been published in the peer-reviewed Nature Partner Journal, npj Digital Medicine. The company said the publication – ‘Identification of acute exacerbations of chronic obstructive pulmonary disease using simple patient-reported symptoms and cough feature analysis’ – builds on the preliminary top-line data from the study that was released in April 2019.

Australia
Sydney
New-south-wales
Pilbara
Western-australia
Kirsty-garrett
Tony-keating
Resapp-health
Breathe-easy
App-health
Nature-partner-journal
ஆஸ்திரேலியா